Biotech

All Articles

Lykos are going to talk to FDA to rethink its own choice complying with being rejected of MDMA treatment for post-traumatic stress disorder

.Following a bad showing for Lykos Therapeutics' MDMA candidate for post-traumatic stress disorder a...

AN 2 one-halfs census, stops period 3 test after records dissatisfy

.AN2 Rehabs is actually rethinking its own service in response to uninspired midphase records, vowin...

Merck pays out $700M for bispecific, snooping autoimmune opening and possibility to test Amgen in cancer

.Merck &amp Co. is actually paying for $700 thousand beforehand to test Amgen in a blood cancer cell...

Gilead pays for J&ampJ $320M to leave licensing offer for seladelpar

.Along With Gilead Sciences on the verge of an FDA selection for its liver health condition medicine...

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks can see the providers putting together camping tents at basecamp responsible for El...

Entero laying off personnel, leaving office and also stopping briefly R&ampD

.Cushion Liquidators has actually switched Entero Rehabs white colored as a piece. The collector ord...

Exelixis loses ADC after determining it's no suit for Tivdak

.Exelixis is losing hope on its own cells variable (TF)- targeting antibody-drug conjugate after wra...

Relay loses interest in SHP2 prevention after Genentech leaves

.3 full weeks after Roche's Genentech system ignored an SHP2 prevention treaty, Relay Rehab has veri...

Stoke's Dravet syndrome med discharged of partial scientific grip

.Stoke Rehabs' Dravet syndrome medicine has actually been actually without a predisposed hold, clear...

Fierce Biotech's Gabrielle Masson offers Strong 15 at NYSE

.Fierce Biotech Affiliate Editor Gabrielle Masson provided the 2024 class of Strong 15 champions on ...